Ticker Symbol: INCY
Incyte Corp.
$65.72 - 02-12-2024 4 p.m. ET
Exchange: NASDAQ
Country:
US
Currency:
USD
Asset
Type: Common Stock
CIK:0000879169
Company Profile
Incyte is a Wilmington, Delaware-based, global biopharmaceutical company focused on finding solutions for serious unmet medical needs through the discovery, development and commercialization of proprietary therapeutics.
Sector: Professional, Scientific, and Technical Services
Industry: Research and Development in the Physical, Engineering, and Life Sciences (except Biotechnology)
Standard Industrial Classification Code (SIC code): 8731
Address: 1801 Augustine Cut off
Website: www.incyte.com
CEO: Herve Hoppenot
Tags:
- Health Technology
- Biotechnology
Pricing
Last Updated: October 3, 2023 03:00 PM EST
Previous Close: $58.56
Change:
$0.50
(
0.86%)
Days Range: $57.56 - $58.68
Beta: 0.28
52wk. High: $86.29
52wk. Low: $54.98
Ytd. Change -26.85%
50 Day Moving Average: $59.44
200 Day Moving Average: $63.98
Shares Outstanding: 224087695
Valuation
Market Cap: 1.3T
PE Ratio: 35.93
EPS (TTM): 1.63
Dividends
Dividend Per Share (TTM): -
Dividend Yield (TTM): 0.00%
Ex-Dividend Date: N/A